Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Apr 15, 2022; 14(4): 897-919
Published online Apr 15, 2022. doi: 10.4251/wjgo.v14.i4.897
Table 3 Prognostic factors of patients with gastric cancer by univariate and multivariate analyses based on logistic regression analysis in the expansive growth type group
Characteristics
INFa
Univariate analysis
Multivariate analysis
HR (95%CI)
P value
HR (95%CI)
P value
Sex0.584
Male1
Female1.261 (0.550-2.894)
Age (yr)1.019 (0.979-1.061)0.349
BMI0.880 (0.772-1.003)0.055
SII1.002 (1.001-1.003)0.0011.001 (1.000-1.003)0.039
ALT0.988 (0.954-1.023)0.491
Total protein0.968 (0.916-1.023)0.251
CEA1.030 (0.996-1.065)0.087
CA19-91.002 (0.998-1.006)0.278
Borrmann type0.0070.272
0-111
23.818 (0.448-32.517)0.2205.312 (0.450-62.711)0.185
38.947 (1.135-70.530)0.0385.450 (0.496-59.870)0.166
4-523.333 (2.525-215.647)0.00514.134 (0.944-211.701)0.055
Tumor location0.691
Lower third1
Middle third1.176 (0.366-3.782)0.785
Upper third1.667 (0.167-16.657)0.664
Entire stomach5.000 (0.303-82.520)0.261
Tumor size (mm)1.032 (1.016-1.049)< 0.0011.012 (0.989-1.034)0.310
pTNM stage< 0.0010.796
I11
II2.615 (0.747-9.159)0.1330.660 (0.154-2.830)0.576
III10.968 (3.457-34.794)< 0.0010.532 (0.080-3.525)0.513
Histological type0.160
Well and medium differentiation1
Poor differentiation2.282 (0.972-5.360)0.058
Others1.617 (0.527-4.959)0.401
mLNR438.799 (38.101-5053.535)< 0.001471.355 (8.218-27035.275)0.003
Vascular infiltration0.080
No1
Yes2.065 (0.917-4.647)
Nerve infiltration0.0250.621
No11
Yes2.432 (1.118-5.288)1.286 (0.474-3.490)
Postoperative chemotherapy0.720
Yes1
No1.159 (0.517-2.597)